Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Marta Khoylou"'
Autor:
Joachim Pfister, Dominik Summer, Milos Petrik, Marta Khoylou, Alexander Lichius, Piriya Kaeopookum, Laurin Kochinke, Thomas Orasch, Hubertus Haas, Clemens Decristoforo
Publikováno v:
Biomolecules, Vol 10, Iss 2, p 168 (2020)
Aspergillus fumigatus (A. fumigatus) is a human pathogen causing severe invasive fungal infections, lacking sensitive and selective diagnostic tools. A. fumigatus secretes the siderophore desferri-triacetylfusarinine C (TAFC) to acquire iron from the
Externí odkaz:
https://doaj.org/article/52a355ae94314066801c38178cca5de0
Autor:
Silvia Surinova, Meena Choi, Sha Tao, Peter J Schüffler, Ching‐Yun Chang, Timothy Clough, Kamil Vysloužil, Marta Khoylou, Josef Srovnal, Yansheng Liu, Mariette Matondo, Ruth Hüttenhain, Hendrik Weisser, Joachim M Buhmann, Marián Hajdúch, Hermann Brenner, Olga Vitek, Ruedi Aebersold
Publikováno v:
EMBO Molecular Medicine, Vol 7, Iss 9, Pp 1166-1178 (2015)
Abstract Non‐invasive detection of colorectal cancer with blood‐based markers is a critical clinical need. Here we describe a phased mass spectrometry‐based approach for the discovery, screening, and validation of circulating protein biomarkers
Externí odkaz:
https://doaj.org/article/38dba3731a4d435cbe003ef84e6e0f61
Autor:
Monika Vidlarova, Emil Berta, Petr Prasil, Andrea Prokopova, Sona Gurska, Marta Khoylou, Alona Rehulkova, Pavla Kourilova, Josef Chudacek, Marek Szkorupa, Jiri Klein, Jozef Skarda, Josef Srovnal, Marian Hajduch
Publikováno v:
Translational lung cancer research. 11(10)
Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related death with a 5-year survival of only 21%. Reliable prognostic and/or predictive biomarkers are needed to improve NSCLC patient stratification, particularly in curative disease st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a454390f62a8335512db21f7975811a
https://pubmed.ncbi.nlm.nih.gov/36386452
https://pubmed.ncbi.nlm.nih.gov/36386452
Autor:
Falco Reissig, Kristof Zarschler, Zbynek Novy, Milos Petrik, Katerina Bendova, Daniela Kurfurstova, Jan Bouchal, Marie-Charlotte Ludik, Florian Brandt, Klaus Kopka, Marta Khoylou, Hans-Jürgen Pietzsch, Marian Hajduch, Constantin Mamat
Publikováno v:
Theranostics 12(2022), 7203-7215
Rationale: Small 225Ac-labeled prostate-specific membrane antigen (PSMA)-targeted radioconjugates have been described for targeted alpha therapy of metastatic castration-resistant prostate cancer. Transient binding to serum albumin as a highly abunda
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22c8b8c884205da5c842281f61ee28cb
https://www.hzdr.de/publications/Publ-34927-1
https://www.hzdr.de/publications/Publ-34927-1
Autor:
Ching Yun Chang, Ruedi Aebersold, Timothy Clough, Peter J. Schüffler, Josef Srovnal, Sha Tao, Mariette Matondo, Meena Choi, Yansheng Liu, Kamil Vysloužil, Silvia Surinova, Olga Vitek, Joachim M. Buhmann, Marta Khoylou, Hendrik Weisser, Hermann Brenner, Marian Hajduch, Ruth Hüttenhain
Publikováno v:
EMBO Molecular Medicine
EMBO Molecular Medicine, Wiley Open Access, 2015, 7 (9), pp.1166-1178. ⟨10.15252/emmm.201404873⟩
EMBO Molecular Medicine, Wiley Open Access, 2015, 7 (9), pp.1166-1178. ⟨10.15252/emmm.201404873⟩
International audience; Non-invasive detection of colorectal cancer with blood-based markers is a critical clinical need. Here we describe a phased mass spectrometry-based approach for the discovery, screening, and validation of circulating protein b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd504772421eb086ff076410e8f435f9
https://hal-pasteur.archives-ouvertes.fr/pasteur-02573640
https://hal-pasteur.archives-ouvertes.fr/pasteur-02573640
Autor:
Pavel Fabian, Roman Hrstka, Marta Khoylou, Marian Hajduch, Rostislav Vyzula, Ondrej Slaby, Marek Svoboda, Lenka Radová, Peter Grell
Publikováno v:
International Journal of Oncology
Trastuzumab is effective in about half of HER2-positive breast cancer patients. The PI3K/Akt signalling pathway plays an important role in the process of primary and secondary resistance to anti-HER2 targeted therapy. We evaluated the relationship be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f17024e0c66e008fcc0ca8ed7fc47124
https://pubmed.ncbi.nlm.nih.gov/22842582
https://pubmed.ncbi.nlm.nih.gov/22842582
Autor:
Marian Hajduch, Jaroslav Juracek, Marta Khoylou, Jiri Navratil, Markéta Palácová, Marek Svoboda, Pavel Fabian, Peter Grell, Rostislav Vyzula
Publikováno v:
Cancer Research. 74:LB-181
Background: The overexpression of Her-2 (c-erbB2/Neu) in breast cancer is associated with poor prognosis, tumor recurrence and shortened survival. The administration of the trastuzumab significantly improves patients prognosis. However, in spite of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7e0f4b6e7562d2ee73e32ca9dab77b7
https://doi.org/10.1158/1538-7445.am2014-lb-181
https://doi.org/10.1158/1538-7445.am2014-lb-181